Work

Comprehensive molecular profiling of pretreatment metastatic castration resistant prostate cancer (CRPC): Secondary data from NCI 9012, a randomized ETS fusion-stratified phase II trial.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e16038

Authors: Scott A. Tomlins, Dan Robinson, Yi-Mi Wu, Robert J Lonigro, Pankaj Vats, Shanker Kalyana Sundaram, Xuhong Cao, Lakshmi Priya Kunju, Nallasivam Palanisamy, Stephanie Daignault, Rohit Mehra, Javed Siddiqui, Arul M. Chinnaiyan, Felix Yi-Chung Feng, Maha Hussain

Institutions: University of Michigan, Michigan Medicine, Michigan Center for Translational Pathology, U-M Rogel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908188616

Cites:

Cited by: 1

Related to: 10